NeuBase Therapeutics, Inc. (NBSE)
NASDAQ: NBSE · IEX Real-Time Price · USD
0.434
+0.004 (0.88%)
At close: Mar 28, 2024, 3:01 PM
0.445
+0.011 (2.53%)
After-hours: Mar 28, 2024, 6:46 PM EDT
NeuBase Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for NBSE.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for NBSE.
Recommendation Trends
Rating | May '22 | Jun '22 | Jul '22 | Aug '22 | Sep '22 | Oct '22 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 21, 2022 |
RBC Capital | RBC Capital | Buy → Hold Downgrades $240 → $20 | Buy → Hold | Downgrades | $240 → $20 | +4,508.29% | Oct 18, 2022 |
Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 17, 2022 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $180 → $140 | Strong Buy | Maintains | $180 → $140 | +32,158.06% | Aug 12, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $300 → $200 | Strong Buy | Maintains | $300 → $200 | +45,982.95% | May 31, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.53
from -20.80
EPS Next Year
-9.18
from -6.53
Revenue Forecast
Revenue | 2023 | 2024 | 2025 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2023 | 2024 | 2025 |
---|---|---|---|
High | -6.72 | -9.45 | -11.97 |
Avg | -6.53 | -9.18 | -11.63 |
Low | -6.27 | -8.82 | -11.17 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.